$IDYA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDEAYA Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IDEAYA Biosciences, Inc.. Get notifications about new insider transactions in IDEAYA Biosciences, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Option Exercise | M | 6.92 | 5,000 | 34,600 | 52,500 | |
May 13 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Sell | S | 20.22 | 5,000 | 101,093 | 98,789 | 103.8 K to 98.8 K (-4.82 %) |
May 13 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Buy | M | 6.92 | 5,000 | 34,600 | 103,789 | 98.8 K to 103.8 K (+5.06 %) |
Feb 26 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Option Exercise | A | 19.52 | 80,000 | 1,561,600 | 80,000 | |
Feb 26 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Option Exercise | A | 19.52 | 45,000 | 878,400 | 45,000 | |
Feb 26 2021 | IDYA | IDEAYA Biosciences ... | Throne Jason | SVP, General Counse ... | Option Exercise | A | 19.52 | 52,500 | 1,024,800 | 52,500 | |
Feb 26 2021 | IDYA | IDEAYA Biosciences ... | Hata Yujiro S | President and CEO | Option Exercise | A | 19.52 | 195,000 | 3,806,400 | 195,000 | |
Feb 26 2021 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, Chief Financia ... | Option Exercise | A | 19.52 | 80,000 | 1,561,600 | 80,000 | |
Feb 17 2021 | IDYA | IDEAYA Biosciences ... | Kelley Susan L. | Director | Option Exercise | A | 18.91 | 22,000 | 416,020 | 22,000 | |
Feb 17 2021 | IDYA | IDEAYA Biosciences ... | Kelley Susan L. | Director | Option Exercise | A | 18.91 | 22,000 | 416,020 | 22,000 | |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Option Exercise | M | 6.92 | 5,000 | 34,600 | 57,500 | |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Sell | S | 20.74 | 5,000 | 103,697 | 98,789 | 103.8 K to 98.8 K (-4.82 %) |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Buy | M | 6.92 | 5,000 | 34,600 | 103,789 | 98.8 K to 103.8 K (+5.06 %) |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Option Exercise | M | 6.98 | 596 | 4,160 | 33,014 | |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Option Exercise | M | 6.98 | 1,104 | 7,706 | 33,610 | |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Option Exercise | M | 6.98 | 300 | 2,094 | 34,714 | |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Sell | S | 21.00 | 596 | 12,516 | 0 | 596 to 0 (-100.00 %) |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Buy | M | 6.98 | 596 | 4,160 | 596 | 0 to 596 |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Sell | S | 21.05 | 1,104 | 23,234 | 0 | 1.1 K to 0 (-100.00 %) |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Buy | M | 6.98 | 1,104 | 7,706 | 1,104 | 0 to 1.1 K |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Sell | S | 21.00 | 200 | 4,200 | 0 | 200 to 0 (-100.00 %) |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Sell | S | 21.02 | 100 | 2,102 | 200 | 300 to 200 (-33.33 %) |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Buy | M | 6.98 | 300 | 2,094 | 300 | 0 to 300 |
Feb 04 2021 | IDYA | IDEAYA Biosciences ... | BVF PARTNERS L P/IL | Sell | S | 18.00 | 4,325 | 77,850 | 233,150 | 237.5 K to 233.2 K (-1.82 %) | |
Feb 04 2021 | IDYA | IDEAYA Biosciences ... | BVF PARTNERS L P/IL | Sell | S | 18.00 | 16,850 | 303,300 | 1,188,131 | 1.2 M to 1.2 M (-1.40 %) | |
Feb 04 2021 | IDYA | IDEAYA Biosciences ... | BVF PARTNERS L P/IL | Sell | S | 18.00 | 25,234 | 454,212 | 1,642,186 | 1.7 M to 1.6 M (-1.51 %) | |
Jan 28 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Option Exercise | M | 6.98 | 1,123 | 7,839 | 35,014 | |
Jan 28 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Option Exercise | M | 4.62 | 377 | 1,742 | 61,760 | |
Jan 28 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Sell | S | 18.79 | 800 | 15,034 | 0 | 800 to 0 (-100.00 %) |
Jan 28 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Sell | S | 18.30 | 1,701 | 31,124 | 800 | 2.5 K to 800 (-68.01 %) |
Jan 28 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Buy | M | 6.98 | 1,123 | 7,839 | 2,501 | 1.4 K to 2.5 K (+81.49 %) |
Jan 28 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Buy | M | 4.62 | 377 | 1,742 | 1,378 | 1 K to 1.4 K (+37.66 %) |
Dec 23 2020 | IDYA | IDEAYA Biosciences ... | Hata Yujiro S | President and CEO | Option Exercise | M | 4.31 | 8,000 | 34,480 | 486,055 | |
Dec 23 2020 | IDYA | IDEAYA Biosciences ... | Hata Yujiro S | President and CEO | Buy | M | 4.31 | 8,000 | 34,480 | 666,286 | 658.3 K to 666.3 K (+1.22 %) |
Dec 22 2020 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Option Exercise | M | 4.31 | 7,750 | 33,403 | 72,735 | |
Dec 22 2020 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Buy | M | 4.31 | 7,750 | 33,403 | 98,789 | 91 K to 98.8 K (+8.51 %) |
Dec 15 2020 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, Chief Financia ... | Buy | J | 0.00 | 444 | 0 | 15,444 | 15 K to 15.4 K (+2.96 %) |
Dec 08 2020 | IDYA | IDEAYA Biosciences ... | Throne Jason | SVP, General Counse ... | Sell | S | 15.55 | 1,579 | 24,548 | 0 | 1.6 K to 0 (-100.00 %) |
Dec 08 2020 | IDYA | IDEAYA Biosciences ... | Throne Jason | SVP, General Counse ... | Sell | S | 14.66 | 400 | 5,862 | 1,579 | 2 K to 1.6 K (-20.21 %) |
Nov 13 2020 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 13.66 | 115,504 | 1,577,785 | 384,496 | 500 K to 384.5 K (-23.10 %) |
Nov 13 2020 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 13.66 | 27,379 | 373,997 | 91,142 | 118.5 K to 91.1 K (-23.10 %) |
Nov 13 2020 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 13.66 | 657,117 | 8,976,218 | 2,187,428 | 2.8 M to 2.2 M (-23.10 %) |
Jul 02 2020 | IDYA | IDEAYA Biosciences ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.32 | 81 | 1,079 | 237,475 | 237.4 K to 237.5 K (+0.03 %) |
Jul 02 2020 | IDYA | IDEAYA Biosciences ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.32 | 929 | 12,371 | 1,204,981 | 1.2 M to 1.2 M (+0.08 %) |
Jul 02 2020 | IDYA | IDEAYA Biosciences ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.32 | 1,521 | 20,254 | 1,667,420 | 1.7 M to 1.7 M (+0.09 %) |
Jul 02 2020 | IDYA | IDEAYA Biosciences ... | Throne Jason | SVP, General Counse ... | Option Exercise | A | 13.34 | 75,000 | 1,000,500 | 75,000 | |
Jun 30 2020 | IDYA | IDEAYA Biosciences ... | Hampton Malcolm Garret | Director | Option Exercise | A | 14.42 | 22,000 | 317,240 | 22,000 | |
Jun 22 2020 | IDYA | IDEAYA Biosciences ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.93 | 1,354 | 18,868 | 237,394 | 236 K to 237.4 K (+0.57 %) |
Jun 22 2020 | IDYA | IDEAYA Biosciences ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.93 | 7,854 | 109,443 | 1,204,052 | 1.2 M to 1.2 M (+0.66 %) |
Jun 22 2020 | IDYA | IDEAYA Biosciences ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.93 | 10,524 | 146,649 | 1,665,899 | 1.7 M to 1.7 M (+0.64 %) |
Jun 22 2020 | IDYA | IDEAYA Biosciences ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 14.39 | 6,769 | 97,403 | 236,040 | 229.3 K to 236 K (+2.95 %) |
Jun 22 2020 | IDYA | IDEAYA Biosciences ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 14.39 | 39,052 | 561,939 | 1,196,198 | 1.2 M to 1.2 M (+3.37 %) |
Jun 22 2020 | IDYA | IDEAYA Biosciences ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 14.39 | 52,443 | 754,629 | 1,655,375 | 1.6 M to 1.7 M (+3.27 %) |
Jun 19 2020 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | Chief Financial Off ... | Option Exercise | M | 4.62 | 3,100 | 14,322 | 137,832 | |
Jun 19 2020 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | Chief Financial Off ... | Sell | S | 19.95 | 600 | 11,968 | 15,000 | 15.6 K to 15 K (-3.85 %) |
Jun 19 2020 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | Chief Financial Off ... | Sell | S | 17.50 | 2,500 | 43,749 | 15,600 | 18.1 K to 15.6 K (-13.81 %) |
Jun 19 2020 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | Chief Financial Off ... | Buy | M | 4.62 | 3,100 | 14,322 | 18,100 | 15 K to 18.1 K (+20.67 %) |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Option Exercise | M | 4.62 | 373 | 1,723 | 62,137 | |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Option Exercise | M | 6.98 | 2,863 | 19,984 | 36,137 | |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Option Exercise | M | 4.62 | 3,887 | 17,958 | 62,510 | |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Sell | S | 19.91 | 373 | 7,428 | 0 | 373 to 0 (-100.00 %) |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Buy | M | 4.62 | 373 | 1,723 | 373 | 0 to 373 |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Sell | S | 14.93 | 6,750 | 100,761 | 0 | 6.8 K to 0 (-100.00 %) |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Buy | M | 6.98 | 2,863 | 19,984 | 6,750 | 3.9 K to 6.8 K (+73.66 %) |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Buy | M | 4.62 | 3,887 | 17,958 | 3,887 | 0 to 3.9 K |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | Morrison Scott W | Director | Option Exercise | A | 12.84 | 11,000 | 141,240 | 11,000 | |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | ROSEN TERRY J | Director | Option Exercise | A | 12.84 | 11,000 | 141,240 | 11,000 | |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Option Exercise | A | 12.84 | 11,000 | 141,240 | 11,000 | |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | Stein Jeffrey | Director | Option Exercise | A | 12.84 | 11,000 | 141,240 | 11,000 | |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | YARNO WENDY L | Director | Option Exercise | A | 12.84 | 11,000 | 141,240 | 11,000 | |
Jun 08 2020 | IDYA | IDEAYA Biosciences ... | Throne Jason | VP, General Counsel | Sell | S | 8.66 | 2,205 | 19,087 | 0 | 2.2 K to 0 (-100.00 %) |
Jun 04 2020 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Sell | S | 10.11 | 104 | 1,051 | 0 | 104 to 0 (-100.00 %) |
Jun 04 2020 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Sell | S | 9.73 | 333 | 3,241 | 104 | 437 to 104 (-76.20 %) |
Jun 04 2020 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Sell | S | 8.55 | 408 | 3,487 | 437 | 845 to 437 (-48.28 %) |
Apr 16 2020 | IDYA | IDEAYA Biosciences ... | Hata Yujiro S | President and CEO | Option Exercise | M | 4.31 | 47,564 | 205,001 | 494,055 | |
Apr 16 2020 | IDYA | IDEAYA Biosciences ... | Hata Yujiro S | President and CEO | Buy | M | 4.31 | 47,564 | 205,001 | 658,286 | 610.7 K to 658.3 K (+7.79 %) |
Apr 01 2020 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | Chief Financial Off ... | Option Exercise | M | 4.62 | 5,000 | 23,100 | 140,932 | |
Apr 01 2020 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | Chief Financial Off ... | Buy | M | 4.62 | 5,000 | 23,100 | 15,000 | 10 K to 15 K (+50.00 %) |
Feb 25 2020 | IDYA | IDEAYA Biosciences ... | Hata Yujiro S | President and CEO | Option Exercise | A | 6.92 | 215,000 | 1,487,800 | 215,000 | |
Feb 25 2020 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Option Exercise | A | 6.92 | 40,000 | 276,800 | 40,000 | |
Feb 25 2020 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Option Exercise | A | 6.92 | 62,500 | 432,500 | 62,500 | |
Feb 25 2020 | IDYA | IDEAYA Biosciences ... | Hambleton Julie | SVP, Chief Medical ... | Option Exercise | A | 6.92 | 62,500 | 432,500 | 62,500 | |
Dec 19 2019 | IDYA | IDEAYA Biosciences ... | ROSEN TERRY J | Director | Option Exercise | A | 9.15 | 1,250 | 11,438 | 1,250 | |
Dec 19 2019 | IDYA | IDEAYA Biosciences ... | Morrison Scott W | Director | Option Exercise | A | 9.15 | 1,250 | 11,438 | 1,250 | |
Dec 19 2019 | IDYA | IDEAYA Biosciences ... | DIEKMAN JOHN D | Director | Option Exercise | A | 9.15 | 11,000 | 100,650 | 11,000 | |
Dec 19 2019 | IDYA | IDEAYA Biosciences ... | Stein Jeffrey | Director | Option Exercise | A | 9.15 | 1,250 | 11,438 | 1,250 | |
Dec 19 2019 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Option Exercise | A | 9.15 | 11,000 | 100,650 | 11,000 | |
Dec 19 2019 | IDYA | IDEAYA Biosciences ... | YARNO WENDY L | Director | Option Exercise | A | 7.36 | 22,000 | 161,920 | 22,000 | |
Oct 11 2019 | IDYA | IDEAYA Biosciences ... | Throne Jason | VP, General Counsel | Option Exercise | A | 7.01 | 75,000 | 525,750 | 75,000 | |
Aug 01 2019 | IDYA | IDEAYA Biosciences ... | Hata Yujiro S | President and CEO | Option Exercise | M | 4.31 | 15,000 | 64,650 | 541,619 | |
Aug 01 2019 | IDYA | IDEAYA Biosciences ... | Hata Yujiro S | President and CEO | Buy | M | 4.31 | 15,000 | 64,650 | 610,722 | 595.7 K to 610.7 K (+2.52 %) |
Jul 30 2019 | IDYA | IDEAYA Biosciences ... | Hager Jeffrey | SVP, Chief Technolo ... | Option Exercise | M | 4.31 | 5,197 | 22,399 | 10,396 | |
Jul 30 2019 | IDYA | IDEAYA Biosciences ... | Hager Jeffrey | SVP, Chief Technolo ... | Buy | M | 4.31 | 5,197 | 22,399 | 127,853 | 122.7 K to 127.9 K (+4.24 %) |
Jul 29 2019 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, General Counse ... | Option Exercise | M | 4.62 | 10,000 | 46,200 | 145,932 | |
Jul 29 2019 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, General Counse ... | Buy | M | 4.62 | 10,000 | 46,200 | 10,000 | 0 to 10 K |
Jul 26 2019 | IDYA | IDEAYA Biosciences ... | Hager Jeffrey | SVP, Chief Technolo ... | Option Exercise | M | 4.31 | 7,145 | 30,795 | 33,275 | |
Jul 26 2019 | IDYA | IDEAYA Biosciences ... | Hager Jeffrey | SVP, Chief Technolo ... | Option Exercise | M | 4.31 | 8,628 | 37,187 | 40,420 | |
Jul 26 2019 | IDYA | IDEAYA Biosciences ... | Hager Jeffrey | SVP, Chief Technolo ... | Buy | M | 4.31 | 7,145 | 30,795 | 122,656 | 115.5 K to 122.7 K (+6.19 %) |
Jul 26 2019 | IDYA | IDEAYA Biosciences ... | Hager Jeffrey | SVP, Chief Technolo ... | Buy | M | 4.31 | 8,628 | 37,187 | 115,511 | 106.9 K to 115.5 K (+8.07 %) |
May 30 2019 | IDYA | IDEAYA Biosciences ... | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 772,499 | 0 | 0 | |
May 30 2019 | IDYA | IDEAYA Biosciences ... | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 3,149,405 | 0 | 0 | |
May 30 2019 | IDYA | IDEAYA Biosciences ... | Alexandria Venture Investments ... | 10% Owner | Buy | P | 10.00 | 50,000 | 500,000 | 432,384 | 382.4 K to 432.4 K (+13.08 %) |
May 30 2019 | IDYA | IDEAYA Biosciences ... | Alexandria Venture Investments ... | 10% Owner | Buy | C | 0.00 | 382,384 | 0 | 382,384 | 0 to 382.4 K |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 24,101 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 71,745 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 578,447 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,721,898 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | P | 10.00 | 500,000 | 5,000,000 | 500,000 | 0 to 500 K |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | P | 10.00 | 10,000 | 100,000 | 118,521 | 108.5 K to 118.5 K (+9.21 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | P | 10.00 | 240,000 | 2,400,000 | 2,844,545 | 2.6 M to 2.8 M (+9.21 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 24,101 | 0 | 108,521 | 84.4 K to 108.5 K (+28.55 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 71,745 | 0 | 84,420 | 12.7 K to 84.4 K (+566.04 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 578,447 | 0 | 2,604,545 | 2 M to 2.6 M (+28.55 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 1,721,898 | 0 | 2,026,098 | 304.2 K to 2 M (+566.04 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | DIEKMAN JOHN D | Director | Option Exercise | C | 0.00 | 24,101 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | DIEKMAN JOHN D | Director | Option Exercise | C | 0.00 | 71,745 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | DIEKMAN JOHN D | Director | Option Exercise | C | 0.00 | 578,447 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | DIEKMAN JOHN D | Director | Option Exercise | C | 0.00 | 1,721,898 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | DIEKMAN JOHN D | Director | Buy | P | 10.00 | 10,000 | 100,000 | 118,521 | 108.5 K to 118.5 K (+9.21 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | DIEKMAN JOHN D | Director | Buy | P | 10.00 | 240,000 | 2,400,000 | 2,844,545 | 2.6 M to 2.8 M (+9.21 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | DIEKMAN JOHN D | Director | Buy | C | 0.00 | 24,101 | 0 | 108,521 | 84.4 K to 108.5 K (+28.55 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | DIEKMAN JOHN D | Director | Buy | C | 0.00 | 71,745 | 0 | 84,420 | 12.7 K to 84.4 K (+566.04 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | DIEKMAN JOHN D | Director | Buy | C | 0.00 | 578,447 | 0 | 2,604,545 | 2 M to 2.6 M (+28.55 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | DIEKMAN JOHN D | Director | Buy | C | 0.00 | 1,721,898 | 0 | 2,026,098 | 304.2 K to 2 M (+566.04 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, General Counse ... | Option Exercise | C | 0.00 | 24,101 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, General Counse ... | Option Exercise | C | 0.00 | 71,745 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, General Counse ... | Option Exercise | C | 0.00 | 578,447 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, General Counse ... | Option Exercise | C | 0.00 | 1,721,898 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, General Counse ... | Buy | P | 10.00 | 10,000 | 100,000 | 118,521 | 108.5 K to 118.5 K (+9.21 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, General Counse ... | Buy | P | 10.00 | 240,000 | 2,400,000 | 2,844,545 | 2.6 M to 2.8 M (+9.21 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, General Counse ... | Buy | C | 0.00 | 24,101 | 0 | 108,521 | 84.4 K to 108.5 K (+28.55 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, General Counse ... | Buy | C | 0.00 | 71,745 | 0 | 84,420 | 12.7 K to 84.4 K (+566.04 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, General Counse ... | Buy | C | 0.00 | 578,447 | 0 | 2,604,545 | 2 M to 2.6 M (+28.55 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, General Counse ... | Buy | C | 0.00 | 1,721,898 | 0 | 2,026,098 | 304.2 K to 2 M (+566.04 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 602,549 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 1,658,164 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Buy | P | 10.00 | 400,000 | 4,000,000 | 2,660,713 | 2.3 M to 2.7 M (+17.69 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 602,549 | 0 | 2,260,713 | 1.7 M to 2.3 M (+36.34 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 1,658,164 | 0 | 1,658,164 | 0 to 1.7 M |
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 602,549 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,658,164 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Buy | P | 10.00 | 400,000 | 4,000,000 | 2,660,713 | 2.3 M to 2.7 M (+17.69 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 602,549 | 0 | 2,260,713 | 1.7 M to 2.3 M (+36.34 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 1,658,164 | 0 | 1,658,164 | 0 to 1.7 M |
Page: 1